ECOPNET May 19, 2021EMA Evaluates Use of Olumiant in Hospitalised COVID-19 Patients Requiring Supplemental OxygenEMA has started evaluating an application to extend the use of Olumiant (baricitinib) to include treatment of COVID-19 in hospitalised...
ECOPNET May 19, 2021EMA and ECDC Join Forces for Enhanced Post-Marketing Monitoring of COVID-19 Vaccines in EuropeOn 26 April, the European Medicines Agency (EMA) and the European Centre for Disease Prevention and Control (ECDC) kicked off a new...
ECOPNET May 17, 2021Clinical Trials Information System Reaches Major Milestone EMA’s Management Board confirmed that the clinical trial EU Portal and Database, one of the main deliverables of the Clinical Trial...